Leishmaniasis remains a major public health problem worldwide with a prevalence of 12 million, an incidence of 1 million persons, and 350 million people being at risk. Murine models have been largely used for studying the host-pathogen relationship and developing effective chemotherapies against Leishmania parasites. Thus, preclinical imaging is crucial for monitoring the disease outcome.
[Background] Leishmania parasites are the causative agents of the neglected tropical disease known as leishmaniasis. The disease outcome varies depending on different factors including the infecting species, the immune response of the host, the presence of an endosymbiotic virus within Leishmania parasites (Ives et al., 2011) , or the co-infection with viruses such human immunodeficiency virus (HIV) or lymphocytic choriomeningitis mammarenavirus (LCMV) which can be detrimental for disease exacerbation (van Griensven et al., 2014; Rossi et al., 2017) . Therefore, the study of parasite persistence using murine models has emerged in the past years . The quantification of parasite burden in experimental models of Leishmania infection has been commonly quantified by either Real-Time Quantitative Reverse Transcription PCR (qRT-PCR) or by limiting dilution assays upon euthanasia of animals . In this protocol, we report a non-invasive technique for the quantification of parasite burden during the disease progression using luciferase expressing parasites (Ives et al., 2011; Hartley et al., 2018) . Moreover, this approach can also be applied for the in vivo detection of other chemiluminescent agents such as luminol that is used as a readout of myeloperoxidase (MPO) activity in acute and chronic inflammatory diseases, or for any other organism expressing luciferase. c. Once the computer is on, access the MI software and select Capture Xtreme BI 4MP.
Materials and Reagents
d. Allow the camera to reach its working temperature of -90 °C. The CCD Operating Temperature box will change from red to green when the camera is ready to use.
Note: The duration of this step is approximate 10 min. e. Input predetermined capture parameters ( 
Data analysis

A. Image Overlay
Luminescence image overlay can be performed either with X-Ray or Reflectance image.
Example using Luminescence and X-Ray images:
1. Open the Luminescence (foreground) image with the MI software ( Figure 3A ). Luciferin is reconstituted to a concentration of 15 mg/ml in DPBS. Filter the solution using a 0.22 μm pore size filter and 50 ml syringe. Aliquot and store at -20 °C. Aliquots are thawed at RT prior to injection
Remove the background of the Luminescence image by clicking on
